Intermountain Health Focussing on Improving Outcomes for Critically Ill

Intermountain Health

Treatment for sepsis, pneumonia, and acute respiratory distress syndrome has been mostly unknown for decades, but that may be about to change.

Dr Samuel Brown, Vice President, Research and Research Professor at Intermountain Health said, “The reality is that ARDS and pneumonia and sepsis, which are pretty similar syndromes, are really like bananas and oranges and apples and papayas and guavas and we’ve just been treating them all as if they were a fruit and what works for apples ought to work for the rest.”

The most prevalent and incapacitating conditions found in critically ill patients are acute respiratory distress syndrome, pneumonia, and sepsis. In a larger group of 22 hospitals across the nation and a clinical coordinating centre at the Vanderbilt University Medical Centre, Intermountain Health was selected as one of six core health care systems on Tuesday to spearhead a national initiative to enhance treatment for these patients.

Each year, sepsis, pneumonia, and acute respiratory distress syndrome cause hundreds of thousands of fatalities in the United States. According to a press release from Intermountain Health, pneumonia, a syndrome in and of itself, is the most common cause of acute respiratory distress syndrome and sepsis, with poor outcomes: up to 50% mortality rate, and for survivors there is often a reduced quality of life and an ongoing risk for early death.

In order to better understand what is happening to 5,000 patients across the nation during and after their illnesses, the institutions participating in the federally financed effort will receive a $51.6 million grant from the National Institutes of Health.

Read More: Click Here